Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9402550 | Journal of Surgical Research | 2005 | 10 Pages |
Abstract
caTLR4 increases the CTL-inducing capacity of DC generating a lytic response specific for the accompanying antigen. These results demonstrate the possibility of enhancing the immunogenicity of the native MART-1 and other RNA derived from weakly immunogenic tumors in DC-based immunotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Zeinab Ph.D., Robin M.D., Jens Ph.D., Tomio M.D., Omar M.D., Matthew F. M.D., Mark W. M.D., Douglas S. M.D., Scott K. M.D., Ph.D.,